This is a preview of subscription content
Subscription info for Chinese customers
We have a dedicated website for our Chinese customers. Please go to naturechina.com to subscribe to this journal.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Kelly, R. J. et al. Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer. N. Engl. J. Med. 384, 1191–1203 (2021)
About this article
Cite this article
Hindson, J. Adjuvant nivolumab for resected gastroesophageal cancer. Nat Rev Gastroenterol Hepatol 18, 368 (2021). https://doi.org/10.1038/s41575-021-00466-w